Calcium-channel blockers linked to reduced risk of Parkinson's disease
This article has no abstract so we have provided the first paragraph of the full text.
Angiotensin-converting-enzyme inhibitors and calcium-channel blockers, drugs commonly used as antihypertensives, have shown possible neuroprotective effects in recent studies. To explore this issue further, Becker and colleagues carried out a case–control analysis to investigate whether use of antihypertensive medications reduced the risk of developing Parkinson's disease (PD).
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.